Exposure to hypoxia following irradiation increases radioresistance in prostate cancer cells

Urol Oncol. 2013 Oct;31(7):1106-16. doi: 10.1016/j.urolonc.2011.10.008. Epub 2011 Nov 29.

Abstract

Background: Tumor hypoxia is a common feature of prostate tumors associated with the stabilization of hypoxia-inducible-factor 1alpha (HIF-1α) and poor prognosis following radiation therapy. Lack of oxygen at the time of irradiation is associated with radioresistance, but recent reports suggest radioresponse is also modulated by the dynamic nature of tumor hypoxia.

Objective: We proposed to evaluate the effect of post-irradiation hypoxic exposure on the radioresponse of 2 prostate cancer (CaP) cell lines (22Rv1, DU145) and to examine whether it correlates with modified cellular responses induced by hypoxia.

Methods and results: Aerobic and hypoxic CaP cells exposed to hypoxia (24 h) after irradiation (4 Gy) gained a survival advantage compared with cells fully oxygenated after irradiation. This survival advantage was associated with induction of a G2/M cell cycle arrest, reduced induction of apoptosis and decreased amount of senescent cells. These modified cellular responses appeared mediated by HIF-1α.

Conclusion: Our data suggest that targeting hypoxia after irradiation may benefit patients with aggressive hypoxic prostate tumors.

Keywords: HIF-1; Hypoxia; Prostate cancer; Radiation; Resistance.

MeSH terms

  • Apoptosis / radiation effects*
  • Blotting, Western
  • Cell Hypoxia
  • Cell Line, Tumor
  • Cell Proliferation / radiation effects*
  • Cell Survival / radiation effects
  • Cellular Senescence / radiation effects*
  • Flow Cytometry
  • G2 Phase Cell Cycle Checkpoints / radiation effects*
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit / metabolism
  • Male
  • Prostatic Neoplasms / metabolism
  • Prostatic Neoplasms / pathology
  • Reactive Oxygen Species / metabolism
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • HIF1A protein, human
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Reactive Oxygen Species
  • Vascular Endothelial Growth Factor A